Metraipolis › archive › dc_9495faae3828

Therapeutic targeting of MALT1 in oncology: Mechanism, inhibitor development, and clinical prospects — Europe PMC PMID:41783325

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41783325
DOI
10.1002/ccs3.70066
License (as archived)
solo-consultazione
Archived
2026-11-05T10:05:08.501Z
SHA-256 of the archived text
e2b4629bef2a6dd551c7f3184abfd7ad2b90b6faf12a4d4169bdac979e99c59e
Stable URL of this page
https://metraipolis.com/documento/dc_9495faae3828

How to cite

Therapeutic targeting of MALT1 in oncology: Mechanism, inhibitor development, and clinical prospects — Europe PMC PMID:41783325 — Europe PMC (en), https://europepmc.org/article/MED/41783325 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9495faae3828 (Metraipolis archive dc_9495faae3828, sha256 e2b4629bef2a6dd551c7f3184abfd7ad2b90b6faf12a4d4169bdac979e99c59e)
BibTeX
@misc{dc9495faae3828,
  title = {Therapeutic targeting of MALT1 in oncology: Mechanism, inhibitor development, and clinical prospects — Europe PMC PMID:41783325},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41783325},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9495faae3828; sha256 e2b4629bef2a6dd551c7f3184abfd7ad2b90b6faf12a4d4169bdac979e99c59e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41783325. Agents can read the archived copy with the MCP tool read_document.